Inovio Pharmaceuticals Inc (INO): Roche and Inovio Pharmaceuticals partner...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	113
Posts	25553
Boards Moderated	4
Alias Born	02/01/2004

Ubertino

Re: cadillac107 post# 13227

Tuesday, 02/02/2016 11:25:09 AM

Tuesday, February 02, 2016 11:25:09 AM

Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products

Basel, Switzerland and Blue Bell, PA, USA – 10 September 2013

Roche and Inovio Pharmaceuticals partner on Inovio’s prostate cancer and hepatitis B immunotherapy products

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio’s highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B. The licensed compounds are currently in preclinical development and have generated robust T-cell responses in animal models.
....
Roche is the world’s largest biotech company

http://www.roche.com/partnering/partnering_media_and_news/partnering_news-2013-09-10.htm